Allspring Global Investments Holdings, LLC Sarepta Therapeutics, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $53.9 Billion
- Q1 2025
A detailed history of Allspring Global Investments Holdings, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 50,472 shares of SRPT stock, worth $3.07 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
50,472
Previous 85,434
40.92%
Holding current value
$3.07 Million
Previous $10.4 Million
68.99%
% of portfolio
0.01%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding SRPT
# of Institutions
521Shares Held
85.9MCall Options Held
1.55MPut Options Held
1.37M-
Black Rock Inc. New York, NY10.3MShares$628 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$553 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$529 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$263 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$248 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $5.33B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...